SP
CME icon

Sarasin & Partners’s CME Group CME Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$280M Sell
1,014,872
-157,718
-13% -$43.5M 2.78% 13
2025
Q1
$311M Sell
1,172,590
-563,121
-32% -$149M 3.37% 10
2024
Q4
$403M Sell
1,735,711
-19,904
-1% -$4.62M 4.45% 8
2024
Q3
$387M Sell
1,755,615
-246,052
-12% -$54.3M 3.65% 10
2024
Q2
$394M Sell
2,001,667
-282,620
-12% -$55.6M 3.49% 8
2024
Q1
$492M Buy
2,284,287
+30,320
+1% +$6.53M 4.84% 4
2023
Q4
$475M Sell
2,253,967
-233,174
-9% -$49.1M 5.22% 4
2023
Q3
$498M Sell
2,487,141
-200,995
-7% -$40.2M 6.22% 3
2023
Q2
$498M Sell
2,688,136
-1,959,057
-42% -$363M 5.78% 1
2023
Q1
$960M Buy
4,647,193
+2,464,368
+113% +$509M 5.17% 2
2022
Q4
$367M Buy
2,182,825
+442,027
+25% +$74.3M 4.81% 2
2022
Q3
$308M Buy
1,740,798
+148,854
+9% +$26.4M 4.27% 3
2022
Q2
$326M Buy
1,591,944
+9,809
+0.6% +$2.01M 4.11% 4
2022
Q1
$376M Sell
1,582,135
-502,435
-24% -$120M 3.78% 4
2021
Q4
$476M Buy
2,084,570
+37,669
+2% +$8.61M 4.34% 2
2021
Q3
$396M Buy
2,046,901
+163,620
+9% +$31.6M 3.99% 2
2021
Q2
$401M Buy
1,883,281
+28,126
+2% +$5.98M 4.18% 2
2021
Q1
$379M Buy
1,855,155
+75,227
+4% +$15.4M 4.47% 1
2020
Q4
$324M Buy
1,779,928
+260,135
+17% +$47.4M 4.29% 1
2020
Q3
$254M Buy
1,519,793
+122,202
+9% +$20.4M 3.68% 4
2020
Q2
$227M Buy
1,397,591
+59,504
+4% +$9.67M 3.63% 6
2020
Q1
$231M Buy
1,338,087
+17,364
+1% +$3M 4.55% 1
2019
Q4
$265M Buy
1,320,723
+14,178
+1% +$2.85M 4.05% 1
2019
Q3
$276M Buy
1,306,545
+31,497
+2% +$6.66M 4.57% 1
2019
Q2
$248M Buy
1,275,048
+281,767
+28% +$54.7M 4.33% 1
2019
Q1
$163M Sell
993,281
-28,931
-3% -$4.76M 3.15% 11
2018
Q4
$192M Buy
1,022,212
+62,421
+7% +$11.7M 4.18% 2
2018
Q3
$163M Buy
959,791
+21,306
+2% +$3.63M 3.08% 10
2018
Q2
$154M Sell
938,485
-65,753
-7% -$10.8M 3.02% 11
2018
Q1
$162M Buy
1,004,238
+234,845
+31% +$38M 3.18% 8
2017
Q4
$112M Buy
769,393
+300,204
+64% +$43.8M 2.18% 17
2017
Q3
$63.7M Buy
469,189
+119,774
+34% +$16.3M 1.28% 34
2017
Q2
$43.8M Buy
+349,415
New +$43.8M 0.86% 42